drugset / Trial / NCT02032862

Efficacy and Safety of Sage Tablets Compared to Placebo in Menopausal Patients With Hot Flushes and Sweating

NCT02032862 ↗

Phase 4 Terminated 107 enrolled A. Vogel AG
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Sage tablets ( 3400 mg extract from fresh sage leaves, DER 1:17) in a once daily application over 12 treatment weeks are compared against placebo in 200 menopausal patients with ≥ 5 hot flushes daily and a Hyperhidrosis Scale score ≥ 2

Timeline

Start
2013-12
Primary completion
2015-07
Completion
2015-07

Outcome

Outcome not reported

Stopped (Enrollment): “Insufficient recruitment rate”

Drugs

EvaluationDrugModalityDoseRoute
Subject Sage extract Unknown 3400 mg —

Indications

No indication recorded.